Main menu

RainDance Technologies has appointed Kathy Ordoñez to its board of directors. She is senior vice president at Quest Diagnostics, and was previously CEO of Celera. She also held several senior positions at Hoffmann La-Roche and oversaw the formation of Roche Molecular Systems, where she served as president and CEO.

Get the full story with GenomeWeb Premium

Only $95 for the first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

This webinar will discuss the benefits of a rapid targeted next-generation sequencing (TNGS) panel, using dried blood spots, for second-tier newborn metabolic and hearing loss screening and its immediate utility for high-risk diagnostic testing in the neonatal intensive care unit.